| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/DKW573 |
| P698 | PubMed publication ID | 28093485 |
| P50 | author | José Manuel Rodríguez Martínez | Q54449621 |
| Fernando Docobo-Pérez | Q57016958 | ||
| Alvaro Pascual | Q60594097 | ||
| Jesus Blazquez | Q68273789 | ||
| Inés Portillo-Calderón | Q95653267 | ||
| M Ballestero-Téllez | Q114311191 | ||
| M S Ramos-Guelfo | Q114311192 | ||
| Jesús Rodríguez-Baño | Q39065635 | ||
| P2093 | author name string | L Racero | |
| P2860 | cites work | E. coli genome manipulation by P1 transduction | Q46760894 |
| Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection | Q22122301 | ||
| A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport | Q28266457 | ||
| Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China | Q28547100 | ||
| Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant | Q29615039 | ||
| Carbon catabolite repression in bacteria: many ways to make the most out of nutrients | Q29615329 | ||
| Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli | Q30432933 | ||
| Promoter elements required for positive control of transcription of the Escherichia coli uhpT gene | Q30435834 | ||
| Biological costs and mechanisms of fosfomycin resistance in Escherichia coli | Q35685710 | ||
| Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan | Q35747796 | ||
| Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance | Q35960788 | ||
| Fosfomycin | Q36675246 | ||
| Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections. | Q40655931 | ||
| Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model | Q40810228 | ||
| Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli | Q43195414 | ||
| Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. | Q44824183 | ||
| Action at a distance for glp repressor control of glpTQ transcription in Escherichia coli K-12. | Q45105122 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 1303-1309 | |
| P577 | publication date | 2017-01-15 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Molecular insights into fosfomycin resistance in Escherichia coli. | |
| P478 | volume | 72 |
| Q48380261 | Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli. |
| Q55093817 | Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors. |
| Q64886188 | New microbiological aspects of fosfomycin. |
| Q48179364 | Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin Uptake. |
Search more.